Dr. Uwe Hanenberg and Dr. Maria Lundin-Johnson, Recipharm, explore the current trends influencing the oral solid dose market and the significant challenges they present to the advancement of medicines.
Olivia Gannon Associate Director of Global MES & Digital Execution Systems in Life Sciences Manufacturing at Cognizant, explores the importance of an effective digitalisation strategy in the life sciences industry.
Latika Mahajan, Assistant Manager, Life Sciences at The Smart Cube explores the declining demand for Covid-19 vaccines and looks ahead to what's next for mRNA.
The National Institute for Health and Care Excellence (NICE) has issued its Final Draft Guidance (FDG) recommending empagliflozin (Jardiance) as an option for the treatment of eligible adults with chronic kidney disease.
Steve Gens of Gens & Associates discusses how a renewed focus on affiliate operations can contribute to resolving data gaps and eliminate inefficiencies within the processes.
Peter Freed, Head of Global Pharma Customer Technical Support at Roquette breaks open mannitol, the mighty molecule, and takes a closer look at some of its underrepresented functionalities.
Whether it’s cost-of-goods or build-versus-buy analysis, eXmoor Pharma’s Harvey Branton, Evelien Stalmeijer and Ruxandra Comisel say a clear understanding of the end goal is key to develop predictive models for cell and gene therapy manufacturing.
The U.S. Food and Drug Administration (FDA) and the Medicines and Healthcare products Regulatory Agency have approved Eli Lilly and Company's Zepbound (Mounjaro) (tirzepatide) injection
The European Commission’s revision of its Good Manufacturing Practices (GMP) Annex 1 for sterile drug products will have implications for pharmaceutical companies that market their sterile drug products in the EU.
